MIT-ADT University
The Bachelor of Science in Nuclear Medicine Technology (B.Sc. NMT) at MIT ADT University, in collaboration with Apollo Healthcare Academy, is a 4-year programme focused on nuclear medicine and molecular imaging technologies. It covers key areas such as radiopharmacy, imaging instrumentation, and radiation safety, with a strong clinical and technical foundation. Students receive practical training and clinical exposure using advanced imaging systems like PET and SPECT, along with internships in nuclear medicine departments. The programme prepares graduates for careers in hospitals, cancer centres, research, and the radiopharmaceutical industry.
Backed by Asia's largest integrated healthcare group with over 40 years of excellence
4-year NCAHP-aligned programme in nuclear medicine and molecular imaging.
Training in radioisotope handling, imaging instrumentation and radiation safety.
Hands-on experience with gamma cameras, PET and SPECT imaging.
Strong emphasis on patient safety, quality control and ethical practice.
From a NAAC Accredited Grade A University.
Domestic and International career opportunities.
Applicants must have completed Class 12 or equivalent from a recognised board with Physics, Chemistry and Biology as main subjects with at least 50% marks. Students with a PCM background and Biology as a supplementary subject are also eligible.
Note: Course content is indicative and subject to change.
| Year | Semester | Courses |
|---|---|---|
| First Year | Semester 1 |
• Basics of Biochemistry & Cell Biology • Human Anatomy and Physiology for Nuclear Medicine • Solid State Physics and Electronics in Nuclear Medicine • Fundamentals of Chemistry • Mathematics in Nuclear Medicine • Practicum – I |
| Semester 2 |
• Introduction to Nuclear Medicine, Medical Ethics and Patient Care • Applied Chemistry: Organic Chemistry & Inorganic Chemistry for Nuclear Medicine • Radiation Physics • Fundamentals of Electromagnetism in Nuclear Medicine • Practicum – II • Clinical Practice – I |
|
| Second Year | Semester 3 |
• Fundamentals of Immunology and Microbiology • Introduction to Radiopharmacy • Nuclear Medicine Instrumentation Physics • Principles of Wave and Optical Physics in Biomedical Imaging • Practicum – III • Clinical Practice – II |
| Semester 4 |
• Radiochemistry • Radiobiology • Biostatistics • Health Physics & Radiation Safety • Practicum – IV • Clinical Practice – III |
|
| Third Year | Semester 5 |
• Radiopharmaceutical Chemistry • Imaging Instruments in Nuclear Medicine • Applications of Computer in Nuclear Medicine • Clinical Nuclear Medicine – I • Practicum – V • Clinical Practice – IV |
| Semester 6 |
• Tomography and Hybrid Imaging • Introduction to AI and Recent Advances in Nuclear Medicine • Clinical Nuclear Medicine – II • Practicum – VI • Clinical Practice – V |
Applicants must have completed 10+2 or equivalent with Physics, Chemistry and Biology as required subjects and a minimum of 50% aggregate marks from a recognised board. Students with a PCM background who take Biology as a supplementary course are also eligible.
The B.Sc. NMT is a 4-year undergraduate degree programme.
Graduates are equipped for dynamic careers in hospitals, cancer centres, nuclear medicine departments, and the radiopharmaceutical industry. Roles include Nuclear Medicine Technologist, PET/SPECT Imaging Specialist, Radiopharmacy Technician, and Quality Assurance Officer in nuclear medicine facilities.
The Dedicated Placement Cell provides comprehensive career support, including resume building, interview preparation and clinical skills assessment. We conduct recruitment drives with various employers visiting the campus.
Students can pursue M.Sc. in Nuclear Medicine Technology, M.Sc. in Radiation Physics, or specialisations in molecular imaging, radiopharmacy, or pursue research and academic roles in nuclear medicine and allied health sciences.
Yes, Nuclear Medicine Technology is a globally recognised profession. With further certification or licensing exams, many graduates work abroad in countries like the UAE, Australia, the UK and Canada.